Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99272
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99272
Table 3 Comparison of immune function indicators between the two groups after treatment (mean ± SD)
Group
CD3+ (%)
CD4+ (%)
CD8+ (%)
CD4+/CD8+
Treg cell (%)
NK cell (%)
Observation
(n = 58)
61.28 ± 5.84a38.84 ± 3.58a21.58 ± 2.08a1.81 ± 0.18a2.08 ± 0.65a21.26 ± 3.28a
Control (n = 58) 52.84 ± 5.80a33.10 ± 3.48a24.63 ± 2.12a1.34 ± 0.14a3.07 ± 0.72a24.95 ± 3.35a
t7.8098.7567.82115.6977.7735.994
P value< 0.001< 0.001< 0.001< 0.001< 0.001< 0.001